s6y
Company name or ticker
Search
Avalo Therapeutics, Inc.
PRE 14A
Preliminary proxy statement not related to a contested matter or merger/acquisition
Filed
Friday, June 7, 2024
Period
Jun 7, 2024
Accession number
0001628280-24-027164
Documents
Preliminary proxy statement not related to a contested matter or merger/acquisition
PRE 14A
On sec.gov
Filing index
All files
Complete submission text
SGML header